key: cord-0846451-5y00y8cs
authors: Liu, Zeming; Long, Wei; Tu, Mengqi; Chen, Sichao; Huang, Yihui; Wang, Shipei; Zhou, Wei; Chen, Danyang; Zhou, Ling; Wang, Min; Wu, Meng; Huang, Qi; Xu, Haibo; Zeng, Wen; Guo, Liang
title: Lymphocyte subset (CD4+, CD8+) counts reflect the severity of infection and predict the clinical outcomes in patients with COVID-19
date: 2020-04-11
journal: J Infect
DOI: 10.1016/j.jinf.2020.03.054
sha: b815dfe9dfb37e67c074c3a80b71bcaecc8e9e60
doc_id: 846451
cord_uid: 5y00y8cs

nan

This retrospective, single-center study was approved by the institutional ethics board of Zhongnan Hospital of Wuhan University, Wuhan, China (No. 2020015). A total of 39 RT-PCR-confirmed COVID-19 patients (admission date from January 18 to February 10, 2020) were enrolled, whose lymphocyte subset counts were tested on admission. The follow-up period lasted till Feb 19, 2020.

We obtained demographic and clinical characteristics and laboratory test results from the electronic medical record system. All data were typed in a pre-designed data collection form and checked to verify data accuracy. Continuous and categorical variables were directly expressed as the median (interquartile range (IQR)) and number (%), respectively. The Mann-Whitney U test was used to compare the lymphocyte subset absolute counts of different conditions and outcomes. All Table 2 .

Counts of lymphocyte and lymphocyte subset are of great value to ensure immune system functionality. Viral infections, immunodeficiency diseases, and other infectious diseases usually lead to abnormal changes in the levels of lymphocyte subsets. (3) (4) (5) In this study, we focused on the abnormal counts of lymphocyte and lymphocyte subset. This result is quite different from that associated with pneumonia caused by common respiratory viruses, such as respiratory syncytial virus, which is typically associated with a normal or elevated lymphocyte count. (6) Here, we found that the CD4+ T cell and CD8+ T cell counts were closely related to disease severity and clinical outcome when we compared the counts of lymphocyte subsets in different patient groups. The more serious the disease and the worse the prognosis, the lower were the T cell, CD4+ T cell, and CD8+ T cell counts on admission. Based on these findings, we believe that the CD4+ and CD8+ T cell counts in patients with COVID-9 could reflect disease severity and predict disease prognosis and are therefore good biomarkers of COVID-19 activity.

In conclusion, lymphocyte subset (CD4+ and CD8+ T cell) counts reflected the disease severity and associated with clinical outcomes, which can be considered as Funding sourses: This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Acknowledgement：None. 

Clinical progression of patients with COVID-19 in Shanghai

National Health Commission of the People's Republic of China. Guidelines for the Diagnosis and Treatment of COVID-19 (Trial Version 6)

Acute primary infection with cytomegalovirus (CMV) in kidney transplant recipients results in the appearance of a phenotypically aberrant CD8(+) T cell population

Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis

Decreased CCR5 expression on CD4(+) T cells of SIV-infected sooty Mangabeys

Respiratory syncytial virus and other respiratory viruses